Cargando…

Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria

OBJECTIVES: The aims of this study were to investigate the occurrence of carbapenem-resistant Gram-negative bacilli (GNB) isolated from inpatients and outpatients in Algeria between July and September 2015, and to screen their resistance mechanisms and genetic relatedness. MATERIALS AND METHODS: A t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourafa, Nadjette, Chaalal, Wafaa, Bakour, Sofiane, Lalaoui, Rym, Boutefnouchet, Nafissa, Diene, Seydina M, Rolain, Jean-Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961646/
https://www.ncbi.nlm.nih.gov/pubmed/29844691
http://dx.doi.org/10.2147/IDR.S150005
_version_ 1783324755763396608
author Bourafa, Nadjette
Chaalal, Wafaa
Bakour, Sofiane
Lalaoui, Rym
Boutefnouchet, Nafissa
Diene, Seydina M
Rolain, Jean-Marc
author_facet Bourafa, Nadjette
Chaalal, Wafaa
Bakour, Sofiane
Lalaoui, Rym
Boutefnouchet, Nafissa
Diene, Seydina M
Rolain, Jean-Marc
author_sort Bourafa, Nadjette
collection PubMed
description OBJECTIVES: The aims of this study were to investigate the occurrence of carbapenem-resistant Gram-negative bacilli (GNB) isolated from inpatients and outpatients in Algeria between July and September 2015, and to screen their resistance mechanisms and genetic relatedness. MATERIALS AND METHODS: A total of 68 non-redundant isolates were identified using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) antibiotic susceptibility testing was performed using disk diffusion and Etest methods. Carbapenemase activity was carried out using modified Carba NP test, EDTA assay, and the modified Hodge test. Molecular characterization of carbapenemases and extended-spectrum β-lactamase (ESBL) genes were detected by standard PCR and sequencing. Genotyping of carbapenem-resistant isolates was performed by multilocus sequence typing (MLST) analysis. RESULTS: Of the 68 GNB isolates, 13 (19%) showed reduced susceptibility to carbapenems, including, four Klebsiella pneumoniae, one Escherichia coli, six Acinetobacter baumannii, and two Pseudomonas aeruginosa. bla(OXA-48) gene was detected in the five Enterobacteriaceae isolates, and bla(OXA-23) was identified in all A. baumannii isolates. OprD mutations were revealed in the two P. aeruginosa isolates. A total of 11 out of the 13 carbapenem-resistant GNB were detected in inpatients, and the two remaining strains were isolated from outpatients. Molecular typing showed the presence of four sequence types (STs) among the OXA-48-producing K. pneumoniae isolates: ST101, ST147, ST163, and ST2017. ST533 was identified for the OXA-48 producing E. coli isolate. All of the A. baumannii and P. aeruginosa were assigned to the international clonal lineages ST2 and ST654, respectively. CONCLUSION: This study reports the first detection of the epidemic multidrug-resistant lineage, K. pneumoniae ST147 coproduced bla(OXA-48) and ESBL genes in Algeria and represents the first description of OXA-48-producing E. coli ST533 and K. pneumoniae ST163 and ST2017. In addition, this study describes for the first time the emergence of OXA-48-producing E. coli and K. pneumoniae in the community in Algeria, leading to major problems for managing microbial infections.
format Online
Article
Text
id pubmed-5961646
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59616462018-05-29 Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria Bourafa, Nadjette Chaalal, Wafaa Bakour, Sofiane Lalaoui, Rym Boutefnouchet, Nafissa Diene, Seydina M Rolain, Jean-Marc Infect Drug Resist Original Research OBJECTIVES: The aims of this study were to investigate the occurrence of carbapenem-resistant Gram-negative bacilli (GNB) isolated from inpatients and outpatients in Algeria between July and September 2015, and to screen their resistance mechanisms and genetic relatedness. MATERIALS AND METHODS: A total of 68 non-redundant isolates were identified using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) antibiotic susceptibility testing was performed using disk diffusion and Etest methods. Carbapenemase activity was carried out using modified Carba NP test, EDTA assay, and the modified Hodge test. Molecular characterization of carbapenemases and extended-spectrum β-lactamase (ESBL) genes were detected by standard PCR and sequencing. Genotyping of carbapenem-resistant isolates was performed by multilocus sequence typing (MLST) analysis. RESULTS: Of the 68 GNB isolates, 13 (19%) showed reduced susceptibility to carbapenems, including, four Klebsiella pneumoniae, one Escherichia coli, six Acinetobacter baumannii, and two Pseudomonas aeruginosa. bla(OXA-48) gene was detected in the five Enterobacteriaceae isolates, and bla(OXA-23) was identified in all A. baumannii isolates. OprD mutations were revealed in the two P. aeruginosa isolates. A total of 11 out of the 13 carbapenem-resistant GNB were detected in inpatients, and the two remaining strains were isolated from outpatients. Molecular typing showed the presence of four sequence types (STs) among the OXA-48-producing K. pneumoniae isolates: ST101, ST147, ST163, and ST2017. ST533 was identified for the OXA-48 producing E. coli isolate. All of the A. baumannii and P. aeruginosa were assigned to the international clonal lineages ST2 and ST654, respectively. CONCLUSION: This study reports the first detection of the epidemic multidrug-resistant lineage, K. pneumoniae ST147 coproduced bla(OXA-48) and ESBL genes in Algeria and represents the first description of OXA-48-producing E. coli ST533 and K. pneumoniae ST163 and ST2017. In addition, this study describes for the first time the emergence of OXA-48-producing E. coli and K. pneumoniae in the community in Algeria, leading to major problems for managing microbial infections. Dove Medical Press 2018-05-17 /pmc/articles/PMC5961646/ /pubmed/29844691 http://dx.doi.org/10.2147/IDR.S150005 Text en © 2018 Bourafa et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Bourafa, Nadjette
Chaalal, Wafaa
Bakour, Sofiane
Lalaoui, Rym
Boutefnouchet, Nafissa
Diene, Seydina M
Rolain, Jean-Marc
Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
title Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
title_full Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
title_fullStr Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
title_full_unstemmed Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
title_short Molecular characterization of carbapenem-resistant Gram-negative bacilli clinical isolates in Algeria
title_sort molecular characterization of carbapenem-resistant gram-negative bacilli clinical isolates in algeria
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961646/
https://www.ncbi.nlm.nih.gov/pubmed/29844691
http://dx.doi.org/10.2147/IDR.S150005
work_keys_str_mv AT bourafanadjette molecularcharacterizationofcarbapenemresistantgramnegativebacilliclinicalisolatesinalgeria
AT chaalalwafaa molecularcharacterizationofcarbapenemresistantgramnegativebacilliclinicalisolatesinalgeria
AT bakoursofiane molecularcharacterizationofcarbapenemresistantgramnegativebacilliclinicalisolatesinalgeria
AT lalaouirym molecularcharacterizationofcarbapenemresistantgramnegativebacilliclinicalisolatesinalgeria
AT boutefnouchetnafissa molecularcharacterizationofcarbapenemresistantgramnegativebacilliclinicalisolatesinalgeria
AT dieneseydinam molecularcharacterizationofcarbapenemresistantgramnegativebacilliclinicalisolatesinalgeria
AT rolainjeanmarc molecularcharacterizationofcarbapenemresistantgramnegativebacilliclinicalisolatesinalgeria